|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PubMed |
16371368 |
Effects of a leukemia-associated gain-of-function mutation of SHP-2 phosphatase on interleukin-3 sig |
2.24 KB |
2019-09-23 |
|
55 |
|
52 |
-
|
| PubMed |
17435236 |
Genetic modifiers of the Drosophila blue cheese gene link defects in lysosomal transport with decrea |
1.58 KB |
2019-09-23 |
|
31 |
|
26 |
-
|
| PubMed |
18031991 |
Isolation and characterization of a novel human RGS mutant displaying gain-of-function activity.
Reg |
1.65 KB |
2019-09-23 |
|
33 |
|
43 |
-
|
| PubMed |
18594199 |
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor maligna |
1.24 KB |
2019-09-23 |
|
29 |
|
42 |
-
|
| PubMed |
19338054 |
Identification and functional analysis of novel variants of the human melanocortin 1 receptor found |
1.9 KB |
2019-09-23 |
|
33 |
|
36 |
-
|
| PubMed |
19917135 |
Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase |
1.68 KB |
2019-09-23 |
|
31 |
|
70 |
-
|
| PubMed |
20399956 |
The tyrosine phosphatase Shp2 in development and cancer.
Deregulation of signaling pathways, through |
1.19 KB |
2019-09-23 |
|
30 |
|
24 |
-
|
| PubMed |
20696700 |
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogramm |
1.45 KB |
2019-09-23 |
|
30 |
|
70 |
-
|
| PubMed |
21175440 |
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation.
AIMS: |
1.69 KB |
2019-09-23 |
|
29 |
|
28 |
-
|
| PubMed |
21187651 |
Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells.
|
1.87 KB |
2019-09-23 |
|
31 |
|
22 |
-
|
